VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1550470
Sex: F
Age: 68
State: IN

Vax Date: 02/10/2021
Onset Date: 02/01/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: when was getting ready for bed, noticed a dime red spot, like a sunburn; low grade fever. , shivery, knew it wasn't high; shivery; pain at the injection site; felt pretty lousy; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (when was getting ready for bed, noticed a dime red spot, like a sunburn), VACCINATION SITE PAIN (pain at the injection site), FATIGUE (felt pretty lousy), PYREXIA (low grade fever. , shivery, knew it wasn't high) and CHILLS (shivery) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. Concomitant products included TRAZODONE, LAMOTRIGINE, VENLAFAXINE and VITAMINS NOS for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site), FATIGUE (felt pretty lousy) and CHILLS (shivery). On an unknown date, the patient experienced RASH MACULAR (when was getting ready for bed, noticed a dime red spot, like a sunburn) and PYREXIA (low grade fever. , shivery, knew it wasn't high). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH MACULAR (when was getting ready for bed, noticed a dime red spot, like a sunburn), VACCINATION SITE PAIN (pain at the injection site), FATIGUE (felt pretty lousy), PYREXIA (low grade fever. , shivery, knew it wasn't high) and CHILLS (shivery) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: TRAZODONE; LAMOTRIGINE; VENLAFAXINE; VITAMINS NOS

Current Illness:

ID: 1550471
Sex: M
Age: 70
State: OH

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Could not sleep; Burning sensation 3 to 4 inches below the injection site; Itching sensation 3 to 4 inches below the injection site; It's irritated /it's annoying; Arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore), BURNING SENSATION (Burning sensation right below where they got the shot), DISCOMFORT (It's irritated /it's annoying), INSOMNIA (Could not sleep) and BURNING SENSATION (Burning sensation 3 to 4 inches below the injection site) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure and Cholesterol. Concomitant products included VITAMINS NOS for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was a little sore). On 16-Feb-2021, the patient experienced BURNING SENSATION (Burning sensation right below where they got the shot), DISCOMFORT (It's irritated /it's annoying), BURNING SENSATION (Burning sensation 3 to 4 inches below the injection site) and INJECTION SITE PRURITUS (Itching sensation 3 to 4 inches below the injection site). On 18-Feb-2021, the patient experienced INSOMNIA (Could not sleep). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm was a little sore), BURNING SENSATION (Burning sensation right below where they got the shot), DISCOMFORT (It's irritated /it's annoying), INSOMNIA (Could not sleep), BURNING SENSATION (Burning sensation 3 to 4 inches below the injection site) and INJECTION SITE PRURITUS (Itching sensation 3 to 4 inches below the injection site) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication also included blood pressure pill and cholesterol pill. Most recent FOLLOW-UP information incorporated above includes: On 20-Feb-2021: No specific follow-up information recorded.

Other Meds: VITAMINS NOS

Current Illness: Blood pressure; Cholesterol

ID: 1550472
Sex: F
Age: 70
State: CA

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: hot; injection site swelling; injection site red; injection site pain; hard at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE ERYTHEMA (injection site red), VACCINATION SITE PAIN (injection site pain) and VACCINATION SITE INDURATION (hard at the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. Concomitant products included HYDROCODONE, LEVOTHYROXINE, METFORMIN, OMEPRAZOLE, VARENICLINE TARTRATE (CHANTIX), TROSPIUM, FLUOXETINE HYDROCHLORIDE (PROZAC), ROPINIROLE, CALCITRIOL and CALCIUM CITRATE for an unknown indication. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE ERYTHEMA (injection site red), VACCINATION SITE PAIN (injection site pain) and VACCINATION SITE INDURATION (hard at the injection site). At the time of the report, VACCINATION SITE WARMTH (hot), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE ERYTHEMA (injection site red), VACCINATION SITE PAIN (injection site pain) and VACCINATION SITE INDURATION (hard at the injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: HYDROCODONE; LEVOTHYROXINE; METFORMIN; OMEPRAZOLE; CHANTIX; TROSPIUM; PROZAC; ROPINIROLE; CALCITRIOL; CALCIUM CITRATE

Current Illness:

ID: 1550473
Sex: M
Age: 85
State: IN

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Felt itchy all over; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Felt itchy all over) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. Concurrent medical conditions included Cholesterol and Heart disorder. Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced PRURITUS (Felt itchy all over). At the time of the report, PRURITUS (Felt itchy all over) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication included cholesterol medication, blood thinners and heart medicine. Treatment information included unspecified lotion and rubbing alcohol. This case was linked to MOD-2021-018473 (Patient Link).

Other Meds: VITAMIN D [VITAMIN D NOS]

Current Illness: Cholesterol; Heart disorder

ID: 1550474
Sex: F
Age: 81
State: FL

Vax Date: 01/19/2021
Onset Date: 01/23/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Severe nose bleed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EPISTAXIS (Severe nose bleed) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039k2014 and 029k2074) for COVID-19 vaccination. Concurrent medical conditions included Sulfonamide allergy, Seasonal allergy and Bronchiectasis (More coughing, increased inflammation). Concomitant products included CELECOXIB for Arthritis, LOSARTAN POTASSIUM for Blood pressure high, RISEDRONATE SODIUM (ACTONEL) from 24-Feb-2021 to an unknown date for Bone density abnormal, ATORVASTATIN for Cholesterol, CITALOPRAM for Depression and Hot flashes. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced EPISTAXIS (Severe nose bleed). At the time of the report, EPISTAXIS (Severe nose bleed) had resolved. Treatment for the events included packing her nose with gauze for the first two episodes and cauterization for the final episode. This case was linked to MOD-2021-018593, MOD-2021-018593 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: The patient's demographics and medical history was updated. The Batch/Lot numbers for mRNA-1273 were updated. Concomitant products used were reported. Two additional events of nose bleed and treatment for all events was reported. Medically confirmed has been updated.

Other Meds: ATORVASTATIN; CELECOXIB; CITALOPRAM; LOSARTAN POTASSIUM; ACTONEL

Current Illness: Bronchiectasis (More coughing, increased inflammation); Seasonal allergy; Sulfonamide allergy

ID: 1550475
Sex: F
Age: 61
State: MD

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: uvula in my throat swelled / my uvula was larger than normal; uvula in my throat turned red / my throat at home and saw it was red.; Allergy to vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ENLARGED UVULA (uvula in my throat swelled / my uvula was larger than normal), PHARYNGEAL ERYTHEMA (uvula in my throat turned red / my throat at home and saw it was red.) and ALLERGY TO VACCINE (Allergy to vaccine) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Allergy to sting (entire body covered in hives, severe itching, very low blood pressure, almost fainted, treated at ER) since 30-Jul-2015, Allergy to antibiotic (Dicloxacillan causes difficulty swallowing) since 24-Oct-1996, Allergy to antibiotic (Ciprofloxacin causes thigh muscle pain) since 2002, Drug allergy (Rosuvastatin causes neck pain, itchy rash on leg) since 15-Apr-2021 and Hypertension since 05-Jan-1999. Concomitant products included BENAZEPRIL HCL from 15-Jan-2016 to an unknown date and HYDROCHLOROTHIAZIDE from 15-Jan-2016 to an unknown date for Hypertension, ASCORBIC ACID, CUPRIC OXIDE, DL-ALPHA TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC OXIDE (PRESERVISION AREDS 2) from 01-Jun-2010 to an unknown date for Retinal drusen, PARACETAMOL (TYLENOL) for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced ENLARGED UVULA (uvula in my throat swelled / my uvula was larger than normal), PHARYNGEAL ERYTHEMA (uvula in my throat turned red / my throat at home and saw it was red.) and ALLERGY TO VACCINE (Allergy to vaccine). On 04-Feb-2021, ENLARGED UVULA (uvula in my throat swelled / my uvula was larger than normal) had resolved. On 05-Feb-2021, PHARYNGEAL ERYTHEMA (uvula in my throat turned red / my throat at home and saw it was red.) and ALLERGY TO VACCINE (Allergy to vaccine) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided by the reporter This case was linked to MOD-2021-248974 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow up received on 26APR2021, updated AE information On 06-Jul-2021: Significant follow-up received on 06JUL2021, updated reporter details, patient demographics, past medical history, patient received 2nd dose on 30APR2021; Lot no 026A21A, Concomitant medications, events end date added.

Other Meds: TYLENOL; BENAZEPRIL HCL; HYDROCHLOROTHIAZIDE; PRESERVISION AREDS 2

Current Illness: Allergy to antibiotic (Dicloxacillan causes difficulty swallowing); Allergy to antibiotic (Ciprofloxacin causes thigh muscle pain); Allergy to sting (entire body covered in hives, severe itching, very low blood pressure, almost fainted, treated at ER); Drug allergy (Rosuvastatin causes neck pain, itchy rash on leg); Hypertension

ID: 1550476
Sex: F
Age: 25
State: FL

Vax Date: 12/31/2020
Onset Date: 02/05/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: experiencing severe pain in lower abdomen, in the pelvis area; Shaking; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of ABDOMINAL PAIN LOWER (experiencing severe pain in lower abdomen, in the pelvis area), TREMOR (Shaking) and NAUSEA (Nausea) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 03AK20A) for COVID-19 vaccination. The patient's past medical history included Lower limb fracture (Patient broke her leg years ago.). On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced ABDOMINAL PAIN LOWER (experiencing severe pain in lower abdomen, in the pelvis area), TREMOR (Shaking) and NAUSEA (Nausea). At the time of the report, ABDOMINAL PAIN LOWER (experiencing severe pain in lower abdomen, in the pelvis area), TREMOR (Shaking) and NAUSEA (Nausea) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medications provided. No treatment information provided. Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Event outcome updated to recovered.

Other Meds:

Current Illness:

ID: 1550477
Sex: F
Age:
State: MN

Vax Date: 01/28/2021
Onset Date: 02/01/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: fatigue/Tiredness; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (fatigue/Tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 01-Feb-2021, the patient experienced FATIGUE (fatigue/Tiredness). At the time of the report, FATIGUE (fatigue/Tiredness) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1550478
Sex: F
Age: 78
State: VA

Vax Date: 01/23/2021
Onset Date: 02/02/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Warm to Touch Sensation - Near Injection Site; Pain - Near Injection Site; Redness - Near Injection Site; Swelling - Near Injection Site; Itchy Sensation - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to Touch Sensation - Near Injection Site), VACCINATION SITE PAIN (Pain - Near Injection Site), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to Touch Sensation - Near Injection Site), VACCINATION SITE PAIN (Pain - Near Injection Site), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site). At the time of the report, VACCINATION SITE WARMTH (Warm to Touch Sensation - Near Injection Site), VACCINATION SITE PAIN (Pain - Near Injection Site), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided. No concomitant medication was provided.

Other Meds:

Current Illness:

ID: 1550479
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 02/01/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: itching; big red oval; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PRURITUS (itching) and VACCINATION SITE ERYTHEMA (big red oval) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 17-Feb-2021, the patient experienced PRURITUS (itching) and VACCINATION SITE ERYTHEMA (big red oval). At the time of the report, PAIN IN EXTREMITY (sore arm), PRURITUS (itching) and VACCINATION SITE ERYTHEMA (big red oval) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. No concomitant medication was provided.

Other Meds:

Current Illness:

ID: 1550480
Sex: F
Age:
State:

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: light fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (light fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (light fever). At the time of the report, PYREXIA (light fever) outcome was unknown. No treatment information was provided. No concomitant medication was provided.

Other Meds:

Current Illness:

ID: 1550481
Sex: F
Age: 56
State: CA

Vax Date: 01/14/2021
Onset Date: 02/10/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Hold onto walls to walk; Tight neck; Mild dizziness; Nausea; Feel worse, cannot exercise; benign paroxysmal vertigo in left ear; Room was spinning; couldn't get up; fatigue; chills; fever; vomited all night/Vomiting triggered; Massive headache; achy all over; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Hold onto walls to walk), MUSCLE TIGHTNESS (Tight neck), VERTIGO (Room was spinning), VERTIGO POSITIONAL (benign paroxysmal vertigo in left ear) and ASTHENIA (Feel worse, cannot exercise) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included BPPV since 18-Feb-2021. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Massive headache) and MYALGIA (achy all over). On 10-Feb-2021 at 6:00 PM, the patient experienced CHILLS (chills) and PYREXIA (fever). 10-Feb-2021 at 6:00 PM, the patient experienced VOMITING (vomited all night/Vomiting triggered). On 11-Feb-2021, the patient experienced FATIGUE (couldn't get up; fatigue). On 11-Feb-2021 at 6:00 AM, the patient experienced VERTIGO (Room was spinning). On 18-Feb-2021, the patient experienced VERTIGO POSITIONAL (benign paroxysmal vertigo in left ear). On 19-Feb-2021, the patient experienced ASTHENIA (Feel worse, cannot exercise). On an unknown date, the patient experienced GAIT DISTURBANCE (Hold onto walls to walk), MUSCLE TIGHTNESS (Tight neck), DIZZINESS (Mild dizziness) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Headache, at a dose of 1 dosage form; MECLOZINE HYDROCHLORIDE (BONINE) on 11-Feb-2021 for Vomiting, at a dose of 1 dosage form; METHYLPREDNISOLONE on 13-Apr-2021 for Vertigo, at an unspecified dose and frequency; Physical therapy for Gait disturbance; Physical therapy for Vertigo; Physical therapy (Epley manuever) for Vertigo positional and Physical therapy for Dizziness. On 12-Feb-2021, CHILLS (chills), MYALGIA (achy all over), PYREXIA (fever) and VOMITING (vomited all night/Vomiting triggered) had resolved. On 15-Apr-2021, VERTIGO (Room was spinning) had resolved with sequelae. At the time of the report, GAIT DISTURBANCE (Hold onto walls to walk) had resolved, MUSCLE TIGHTNESS (Tight neck), DIZZINESS (Mild dizziness), HEADACHE (Massive headache) and NAUSEA (Nausea) had not resolved and VERTIGO POSITIONAL (benign paroxysmal vertigo in left ear), ASTHENIA (Feel worse, cannot exercise) and FATIGUE (couldn't get up; fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 101-101.5 (High) 101-101.5 Fahrenheit. No concomitant medications were reported. Source documents contain NNI Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up information received on 01-JUL-2021 contains address, Patient demographics, First dose information, Second dose batch no, Treatment for vertigo, Adverse events outcome updated. On 22-Jul-2021: NNI

Other Meds:

Current Illness: BPPV

ID: 1550482
Sex: F
Age: 75
State: NY

Vax Date: 01/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), PYREXIA (A little bit of fever) and CHILLS (Chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 029L20A) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced ERYTHEMA (Redness). On an unknown date, the patient experienced PYREXIA (A little bit of fever) and CHILLS (Chills). At the time of the report, ERYTHEMA (Redness), PYREXIA (A little bit of fever) and CHILLS (Chills) outcome was unknown. No Concomitant medications were reported. The patient took Tylenol as treatment medication. This case was linked to MOD-2021-038916 (Patient Link).

Other Meds:

Current Illness:

ID: 1550483
Sex: F
Age: 73
State: NV

Vax Date: 02/06/2021
Onset Date: 02/06/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: body aches; eyes burned; dizzy; fatigued; sore in her arm (injection site); This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (dizzy), FATIGUE (fatigued), VACCINATION SITE PAIN (sore in her arm (injection site)), MYALGIA (body aches) and EYE IRRITATION (eyes burned) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. Concurrent medical conditions included Back pain. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for Supplementation therapy. On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced DIZZINESS (dizzy), FATIGUE (fatigued), VACCINATION SITE PAIN (sore in her arm (injection site)) and EYE IRRITATION (eyes burned). On 07-Feb-2021, the patient experienced MYALGIA (body aches). At the time of the report, DIZZINESS (dizzy), FATIGUE (fatigued), VACCINATION SITE PAIN (sore in her arm (injection site)), MYALGIA (body aches) and EYE IRRITATION (eyes burned) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication nor treatment provided

Other Meds: MULTIVITAMINS [VITAMINS NOS]

Current Illness: Back pain

ID: 1550484
Sex: F
Age:
State: NC

Vax Date: 02/04/2021
Onset Date: 02/01/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: tenderness and soreness at site of injection; itching site of injection; soreness at site of injection; site of injection feels warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (tenderness and soreness at site of injection), VACCINATION SITE PRURITUS (itching site of injection), VACCINATION SITE PAIN (soreness at site of injection) and VACCINATION SITE WARMTH (site of injection feels warm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The patient's past medical history included Mastectomy since an unknown date. Concurrent medical conditions included Hypertension. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (tenderness and soreness at site of injection). In February 2021, the patient experienced VACCINATION SITE PRURITUS (itching site of injection), VACCINATION SITE PAIN (soreness at site of injection) and VACCINATION SITE WARMTH (site of injection feels warm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain and Tenderness, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (tenderness and soreness at site of injection), VACCINATION SITE PRURITUS (itching site of injection), VACCINATION SITE PAIN (soreness at site of injection) and VACCINATION SITE WARMTH (site of injection feels warm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. no concomitant medication provided

Other Meds:

Current Illness: Hypertension; Mastectomy

ID: 1550485
Sex: F
Age: 67
State:

Vax Date: 02/05/2021
Onset Date: 02/04/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (pain in arm), VERTIGO (Vertigo) and NASOPHARYNGITIS (Cold) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. Concurrent medical conditions included Osteoporosis. Concomitant products included RISEDRONATE SODIUM (ACTONEL) from 02-Feb-2021 to an unknown date for Osteoporosis. On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced VERTIGO (Vertigo) and NASOPHARYNGITIS (Cold). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in arm). At the time of the report, PAIN IN EXTREMITY (pain in arm), VERTIGO (Vertigo) and NASOPHARYNGITIS (Cold) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. No concomitant medication nor treatment information provided.

Other Meds: ACTONEL

Current Illness: Osteoporosis

ID: 1550486
Sex: F
Age:
State:

Vax Date: 02/10/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: itching; Red; Ugly; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), ERYTHEMA (Red) and VACCINATION SITE REACTION (Ugly) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PRURITUS (itching), ERYTHEMA (Red) and VACCINATION SITE REACTION (Ugly). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching and Erythema, at an unspecified dose and frequency. At the time of the report, PRURITUS (itching), ERYTHEMA (Red) and VACCINATION SITE REACTION (Ugly) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. no concomitant medication provided Patient was treated symptoms with using Ice This case was linked to MOD-2021-018461 (E2B Linked Report). This case was linked to MOD-2021-018437 (Patient Link).; Sender's Comments: MOD-2021-018461:wife's case

Other Meds:

Current Illness:

ID: 1550487
Sex: F
Age: 71
State: NY

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Extremely thirsty; Arm swollen; Headache; Nose, eyebrow and cheek reddish in color; fever; This spontaneous case was reported by a consumer and describes the occurrence of DEHYDRATION (Extremely thirsty), PERIPHERAL SWELLING (Arm swollen), HEADACHE (Headache), ERYTHEMA (Nose, eyebrow and cheek reddish in color) and PYREXIA (fever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced DEHYDRATION (Extremely thirsty), PERIPHERAL SWELLING (Arm swollen), HEADACHE (Headache), ERYTHEMA (Nose, eyebrow and cheek reddish in color) and PYREXIA (fever). At the time of the report, DEHYDRATION (Extremely thirsty), PERIPHERAL SWELLING (Arm swollen), HEADACHE (Headache), ERYTHEMA (Nose, eyebrow and cheek reddish in color) and PYREXIA (fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. no treatment nor concomitant medication provided

Other Meds:

Current Illness:

ID: 1550488
Sex: F
Age: 80
State: NY

Vax Date: 01/14/2021
Onset Date: 01/29/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: chills; headache; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (chills) and HEADACHE (headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No adverse event reported). On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced CHILLS (chills) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Headache and Chills, at an unspecified dose and frequency. At the time of the report, CHILLS (chills) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication provided Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2021: NNI; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1550489
Sex: F
Age: 54
State: AZ

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: There were no vaccines left at the facility; Did not feel well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Did not feel well) and PRODUCT AVAILABILITY ISSUE (There were no vaccines left at the facility) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MALAISE (Did not feel well). On 17-Feb-2021, the patient experienced PRODUCT AVAILABILITY ISSUE (There were no vaccines left at the facility). On 22-Jan-2021, MALAISE (Did not feel well) had not resolved. On 17-Feb-2021, PRODUCT AVAILABILITY ISSUE (There were no vaccines left at the facility) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported. Treatment information in response to event was not provided

Other Meds:

Current Illness:

ID: 1550490
Sex: M
Age: 66
State: NJ

Vax Date: 01/16/2021
Onset Date: 01/23/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Positive covid test; Slight fever; Sneezing; Cough; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), COUGH (Cough), COVID-19 (Positive covid test) and PYREXIA (Slight fever) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced SNEEZING (Sneezing), COUGH (Cough) and PYREXIA (Slight fever). On 27-Jan-2021, the patient experienced COVID-19 (Positive covid test). At the time of the report, SNEEZING (Sneezing), COUGH (Cough), COVID-19 (Positive covid test) and PYREXIA (Slight fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication nor treatment information provided

Other Meds:

Current Illness:

ID: 1550491
Sex: F
Age: 75
State: AZ

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: swollen arm; hard and raised welt; red arm; hot arm; sore to the touch arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), VACCINATION SITE INDURATION (hard and raised welt), ERYTHEMA (red arm), FEELING HOT (hot arm) and PAIN IN EXTREMITY (sore to the touch arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (no medical history provided). Concomitant products included Omeprazole as needed, UBIDECARENONE (COQ), CALCIUM, SELENIUM, NIACINAMIDE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), DOCUSATE, Loratidine, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), MAGNESIUM, MELATONIN, PSYLLIUM HUSK [PLANTAGO OVATA HUSK], MONASCUS PURPUREUS, NICOTINAMIDE, PHYTOSTEROLS NOS (RED YEAST RICE WITH PLANT STEROLS) and BIOFLAVONOIDS NOS, RESVERATROL, VITIS VINIFERA SEED (GRAPESEED EXTRACT [BIOFLAVONOIDS NOS;RESVERATROL;VITIS VINIFERA SEED]) for an unknown indication. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced HEADACHE (headache). On 10-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen arm), VACCINATION SITE INDURATION (hard and raised welt), ERYTHEMA (red arm), FEELING HOT (hot arm) and PAIN IN EXTREMITY (sore to the touch arm). On 10-Feb-2021, HEADACHE (headache) had resolved. At the time of the report, PERIPHERAL SWELLING (swollen arm), VACCINATION SITE INDURATION (hard and raised welt), ERYTHEMA (red arm), FEELING HOT (hot arm) and PAIN IN EXTREMITY (sore to the touch arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication provided. Patient regularly takes showers.

Other Meds: Omeprazole as needed; COQ; CALCIUM; SELENIUM; NIACINAMIDE; VITAMIN D 2000; DOCUSATE; Loratidine; VITAMIN C & ROSEHIP; MAGNESIUM; MELATONIN; PSYLLIUM HUSK [PLANTAGO OVATA HUSK]; RED YEAST R

Current Illness:

ID: 1550492
Sex: M
Age:
State: CA

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: 5 or 10 minutes after the injection, I got a flushing sensation from the base of the neck up to my jaw; it felt like blood pressure was going up or something; tingliness in the forearm; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (5 or 10 minutes after the injection, I got a flushing sensation from the base of the neck up to my jaw), BLOOD PRESSURE INCREASED (it felt like blood pressure was going up or something) and PARAESTHESIA (tingliness in the forearm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Open heart surgery since an unknown date. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced FLUSHING (5 or 10 minutes after the injection, I got a flushing sensation from the base of the neck up to my jaw), BLOOD PRESSURE INCREASED (it felt like blood pressure was going up or something) and PARAESTHESIA (tingliness in the forearm). On 15-Feb-2021, FLUSHING (5 or 10 minutes after the injection, I got a flushing sensation from the base of the neck up to my jaw), BLOOD PRESSURE INCREASED (it felt like blood pressure was going up or something) and PARAESTHESIA (tingliness in the forearm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications or treatment details reported.

Other Meds:

Current Illness: Open heart surgery

ID: 1550493
Sex: F
Age: 73
State: NY

Vax Date: 02/09/2021
Onset Date: 02/10/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Hot to Touch Sensation - Near Injection Site; Itchy Sensation - Near Injection Site; Redness - Near Injection Site; Swelling - Near Injection Site; Rash - Near Injection Site; Arm Soreness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Soreness), VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (No medical history reported). On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm Soreness). On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE RASH (Rash - Near Injection Site). On 12-Feb-2021, PAIN IN EXTREMITY (Arm Soreness) had resolved. At the time of the report, VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE RASH (Rash - Near Injection Site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details included cefalexin, advised by HCP to try and help alleviate the symptoms.

Other Meds:

Current Illness:

ID: 1550494
Sex: F
Age: 87
State: TN

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Soreness at the injection site that run up to the neck; Little itching at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021. This spontaneous case was reported by a nurse and describes the occurrence of INJECTION SITE PAIN (Soreness at the injection site that run up to the neck) and INJECTION SITE PRURITUS (Little itching at the injection site) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 007M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concurrent medical conditions included heart pace maker. Concomitant products included IRON for an unknown indication. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced INJECTION SITE PAIN (Soreness at the injection site that run up to the neck) and INJECTION SITE PRURITUS (Little itching at the injection site). On 18-Feb-2021, INJECTION SITE PAIN (Soreness at the injection site that run up to the neck) and INJECTION SITE PRURITUS (Little itching at the injection site) had resolved. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Allergy medication, Medication for asthma & Medication that helps her to breathe are taken as concomitant medicines. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: No specific follow-up information recorded.

Other Meds: IRON

Current Illness:

ID: 1550495
Sex: F
Age:
State:

Vax Date: 02/10/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: arm was itching; arm was red; arm was ugly; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (arm was itching), VACCINATION SITE ERYTHEMA (arm was red) and VACCINATION SITE REACTION (arm was ugly) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (arm was itching), VACCINATION SITE ERYTHEMA (arm was red) and VACCINATION SITE REACTION (arm was ugly). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (arm was itching), VACCINATION SITE ERYTHEMA (arm was red) and VACCINATION SITE REACTION (arm was ugly) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported. Other treatment details included applying ice. This case was linked to MOD-2021-018425 (Patient Link). Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1550496
Sex: F
Age:
State:

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Fatigue; Tingly tongue; throat felt itchy; Headache; Nauseous; This spontaneous case was reported by a nurse and describes the occurrence of GLOSSITIS (Tingly tongue), THROAT IRRITATION (throat felt itchy), HEADACHE (Headache), NAUSEA (Nauseous) and FATIGUE (Fatigue) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced GLOSSITIS (Tingly tongue), THROAT IRRITATION (throat felt itchy), HEADACHE (Headache) and NAUSEA (Nauseous). On an unknown date, the patient experienced FATIGUE (Fatigue). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) for Adverse event, at an unspecified dose and frequency; ONDANSETRON (ZOFRAN [ONDANSETRON]) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, GLOSSITIS (Tingly tongue), THROAT IRRITATION (throat felt itchy), HEADACHE (Headache), NAUSEA (Nauseous) and FATIGUE (Fatigue) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported.

Other Meds:

Current Illness:

ID: 1550497
Sex: M
Age:
State: CA

Vax Date: 01/22/2021
Onset Date: 02/03/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Body ache; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (Body ache) and PYREXIA (fever). At the time of the report, PAIN (Body ache) and PYREXIA (fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 104f (Inconclusive) 104F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications was reported Treatment information was not provided

Other Meds:

Current Illness:

ID: 1550498
Sex: F
Age:
State: FL

Vax Date: 01/02/2021
Onset Date: 01/31/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: arm sore; difficulty in going out of bed; fever; headache; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm sore), CLINOMANIA (difficulty in going out of bed), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L02A) for COVID-19 vaccination. Concomitant products included FLUOXETINE, ROSUVASTATIN, AMLODIPINE, CALCIUM, VITAMIN D [VITAMIN D NOS] and VITAMIN B NOS for an unknown indication. On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1. On 31-Jan-2021, the patient experienced PYREXIA (fever), HEADACHE (headache) and CHILLS (chills). On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm sore) and CLINOMANIA (difficulty in going out of bed). At the time of the report, PAIN IN EXTREMITY (arm sore), CLINOMANIA (difficulty in going out of bed), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2020, White blood cell count (3.8-10.8): Low. In June 2020, White blood cell count (3.8-10.8): Low. On 14-Jan-2021, White blood cell count (3.8-10.8): 3.7 Low. On an unknown date, Body temperature: (High) 101F. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. This case was linked to MOD-2021-216190 (Patient Link).; Reporter's Comments: Her treating physician referred that her WBC low is normal for her.

Other Meds: FLUOXETINE; ROSUVASTATIN; AMLODIPINE; CALCIUM; VITAMIN D [VITAMIN D NOS]; VITAMIN B NOS

Current Illness:

ID: 1550499
Sex: U
Age: 63
State: IL

Vax Date: 01/25/2021
Onset Date: 02/03/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (red itchy rash on the injection site), VACCINATION SITE ERYTHEMA (red itchy rash on the injection site) and VACCINATION SITE RASH (red itchy rash on the injection site) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (red itchy rash on the injection site), VACCINATION SITE ERYTHEMA (red itchy rash on the injection site) and VACCINATION SITE RASH (red itchy rash on the injection site). At the time of the report, VACCINATION SITE PRURITUS (red itchy rash on the injection site), VACCINATION SITE ERYTHEMA (red itchy rash on the injection site) and VACCINATION SITE RASH (red itchy rash on the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications reported. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Non significant follow up added. Email address updated.

Other Meds:

Current Illness:

ID: 1550500
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: nose bleed, never had one in her life before; her symptoms have gotten worse; Hand feels that there is Fire in her hands; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose bleed, never had one in her life before), CONDITION AGGRAVATED (her symptoms have gotten worse) and BURNING SENSATION (Hand feels that there is Fire in her hands) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (nose bleed, never had one in her life before), CONDITION AGGRAVATED (her symptoms have gotten worse) and BURNING SENSATION (Hand feels that there is Fire in her hands). At the time of the report, EPISTAXIS (nose bleed, never had one in her life before) outcome was unknown and CONDITION AGGRAVATED (her symptoms have gotten worse) and BURNING SENSATION (Hand feels that there is Fire in her hands) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up received which contains new events of condition aggravated and burning sensation was added

Other Meds:

Current Illness:

ID: 1550501
Sex: F
Age: 57
State: TX

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: bad headache; arm discomfort; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad headache) and LIMB DISCOMFORT (arm discomfort) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (bad headache) and LIMB DISCOMFORT (arm discomfort). At the time of the report, HEADACHE (bad headache) and LIMB DISCOMFORT (arm discomfort) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No corrective treatment and concomitant medication was reported. Consent given for Safety Division to follow up with her if needed.

Other Meds:

Current Illness:

ID: 1550502
Sex: M
Age:
State:

Vax Date: 02/10/2021
Onset Date: 02/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Itching; huge red thing; A spontaneous report was received from a consumer concerning a male patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events itching/pruritus, huge red thing/erythema. The patient's medical history was not provided. No relevant concomitant medications were reported. On 10 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. On 19 Feb 2021, the patient experienced the events, itching, huge red thing. Treatment information include ice and Benadryl. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events, itching, huge red thing was unknown.

Other Meds:

Current Illness:

ID: 1550503
Sex: F
Age: 34
State:

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: fever of 101.2 F; Vaccine exposure during pregnancy; and stomach ache; fatigue; headache; itchy arm; tender arm; hot arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), VACCINATION SITE WARMTH (hot arm), VACCINATION SITE PRURITUS (itchy arm) and VACCINATION SITE PAIN (tender arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot arm), VACCINATION SITE PRURITUS (itchy arm) and VACCINATION SITE PAIN (tender arm). On 17-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 28-Jan-2021, VACCINATION SITE WARMTH (hot arm), VACCINATION SITE PRURITUS (itchy arm) and VACCINATION SITE PAIN (tender arm) had resolved. At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 101.2 (High) 101.2 F. On 17-Feb-2021, COVID-19: negative (Negative) She tested negative for COVID. This case was linked to MOD-2021-016110 (Patient Link).

Other Meds:

Current Illness:

ID: 1550504
Sex: M
Age: 68
State: NY

Vax Date: 01/21/2021
Onset Date: 02/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Progressive and gradual pain at the neck; Sore arm; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 20-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Progressive and gradual pain at the neck), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032120A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced NECK PAIN (Progressive and gradual pain at the neck), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). At the time of the report, NECK PAIN (Progressive and gradual pain at the neck), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) outcome was unknown. This case was linked to MOD-2021-091001, MOD-2021-091001 (Patient Link). Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1550505
Sex: F
Age: 94
State: NY

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Redness at the injection site; Hardness at the injection site; Itchiness at the injection site; A spontaneous report was received from a 94 year old , female patient , who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced redness at the injection site/vaccination site erythema , hardness at the injection site/ vaccination site induration and itchiness at the injection site/vaccination site pruritis. The patient's medical history was not provided. Concomitant product use was not provided. On an unknown date, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273(Batch number : unknown) via unknown route for prophylaxis of COVID-19 infection. On 19 Feb 2021, prior to the onset of events, the patient received their second of two planned doses of mRNA-1273 (Batch number : unknown) intramuscularly for prophylaxis of COVID-19 infection. On 19 Feb 2021, after receiving mRNA-1273, the patient experienced redness , hardness and itching at the injection site. The reporter wants to know what to do regarding her symptoms. Treatment information was not provided. The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable. The outcome of the events, redness, hardness and itching at the injection site were not considered to be resolved at the time of report.

Other Meds:

Current Illness:

ID: 1550506
Sex: F
Age: 68
State: NY

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Single hive on bettly/Hive an inch below injection site/Hive on face above eyebrow; Intense itching above injection site; Splotchy rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Single hive on bettly/Hive an inch below injection site/Hive on face above eyebrow), VACCINATION SITE PRURITUS (Intense itching above injection site) and RASH (Splotchy rash) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012m20a) for COVID-19 vaccination. Concomitant products included VITAMINS NOS for an unknown indication. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Single hive on bettly/Hive an inch below injection site/Hive on face above eyebrow), VACCINATION SITE PRURITUS (Intense itching above injection site) and RASH (Splotchy rash). At the time of the report, VACCINATION SITE URTICARIA (Single hive on bettly/Hive an inch below injection site/Hive on face above eyebrow), VACCINATION SITE PRURITUS (Intense itching above injection site) and RASH (Splotchy rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-090160 (Patient Link).

Other Meds: VITAMINS NOS

Current Illness:

ID: 1550507
Sex: F
Age: 76
State: FL

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (extremely dizzy similar or worse than Vertigo, dizziness is worsening by the hour) and CONDITION AGGRAVATED (Extremely dizzy) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for an unknown indication. Concurrent medical conditions included Diabetes. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced DIZZINESS (extremely dizzy similar or worse than Vertigo, dizziness is worsening by the hour) and CONDITION AGGRAVATED (Extremely dizzy). On 22-Feb-2021, DIZZINESS (extremely dizzy similar or worse than Vertigo, dizziness is worsening by the hour) and CONDITION AGGRAVATED (Extremely dizzy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications was reported. No treatment details was specified. Reporter did not allow further contact. Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow up received on 26 Apr 2021 included: reporter contact details, updated the outcome of the event (dizziness) and patient's medical history.

Other Meds:

Current Illness: Diabetes

ID: 1550508
Sex: F
Age: 71
State: CT

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: the arm of the shot has been very achy; mild headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE PAIN (the arm of the shot has been very achy) and HEADACHE (mild headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (the arm of the shot has been very achy) and HEADACHE (mild headache). At the time of the report, VACCINATION SITE PAIN (the arm of the shot has been very achy) and HEADACHE (mild headache) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1550509
Sex: M
Age: 56
State: CA

Vax Date: 02/11/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: right ankle joint so much in pain; couldn't walk for 24 hours; elbow pain; neck pain on the left side; wrist pain; severe pain in his left shoulder; fingers pain; pain left cervical; severe pain in his left arm; weakness left cervica; This spontaneous case was reported by a nurse and describes the occurrence of ARTHRALGIA (right ankle joint so much in pain), GAIT DISTURBANCE (couldn't walk for 24 hours), ARTHRALGIA (elbow pain), NECK PAIN (neck pain on the left side) and ARTHRALGIA (wrist pain) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure high. On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced ARTHRALGIA (right ankle joint so much in pain), GAIT DISTURBANCE (couldn't walk for 24 hours), ARTHRALGIA (elbow pain), NECK PAIN (neck pain on the left side), ARTHRALGIA (wrist pain), ARTHRALGIA (severe pain in his left shoulder), PAIN IN EXTREMITY (fingers pain), NECK PAIN (pain left cervical), PAIN IN EXTREMITY (severe pain in his left arm) and ASTHENIA (weakness left cervica). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (right ankle joint so much in pain), GAIT DISTURBANCE (couldn't walk for 24 hours), ARTHRALGIA (elbow pain), NECK PAIN (neck pain on the left side), ARTHRALGIA (wrist pain), ARTHRALGIA (severe pain in his left shoulder), PAIN IN EXTREMITY (fingers pain), NECK PAIN (pain left cervical), PAIN IN EXTREMITY (severe pain in his left arm) and ASTHENIA (weakness left cervica) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product information was not provided

Other Meds:

Current Illness: Blood pressure high

ID: 1550510
Sex: M
Age: 35
State: IN

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over) and PRURITUS (his entire body was itching) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (Medical history was not reported.). Concurrent medical conditions included Cholesterol and Heart disease, unspecified. Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced PRURITUS (Itching all over). On 17-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (his entire body was itching). At the time of the report, PRURITUS (Itching all over) outcome was unknown and PRURITUS (his entire body was itching) had not resolved. Treatment information included Lotion,Rubbing alcohol. Concomitant med also include: Blood thinners and heart medicine This case was linked to MOD-2021-018398 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: NNI

Other Meds: VITAMIN D 2000

Current Illness: Cholesterol; Heart disease, unspecified

ID: 1550511
Sex: F
Age: 31
State: DE

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Anxiety; Headache; Soreness at injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), HEADACHE (Headache), INJECTION SITE PAIN (Soreness at injection site) and FATIGUE (Fatigue) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced HEADACHE (Headache), INJECTION SITE PAIN (Soreness at injection site) and FATIGUE (Fatigue). On 19-Feb-2021, the patient experienced ANXIETY (Anxiety). At the time of the report, ANXIETY (Anxiety) outcome was unknown and HEADACHE (Headache), INJECTION SITE PAIN (Soreness at injection site) and FATIGUE (Fatigue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not reported Treatment information was not provided Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1550512
Sex: F
Age: 32
State: IL

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Stinging sensation; Slight headache; Arm started hurting; Hands were tingling; Felt numb; Rapid heartbeat/ heart was racing; Chills on and off; Dizziness; Foggy feeling in brain; Vaccination site erythema; Bruised; Hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling) and HYPOAESTHESIA (Felt numb) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Food allergy (Shrimp). On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling), HYPOAESTHESIA (Felt numb), HEART RATE INCREASED (Rapid heartbeat/ heart was racing), CHILLS (Chills on and off), DIZZINESS (Dizziness), FEELING ABNORMAL (Foggy feeling in brain), VACCINATION SITE ERYTHEMA (Vaccination site erythema), CONTUSION (Bruised) and VACCINATION SITE WARMTH (Hot to the touch). At the time of the report, PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling), HYPOAESTHESIA (Felt numb), HEART RATE INCREASED (Rapid heartbeat/ heart was racing), CHILLS (Chills on and off), DIZZINESS (Dizziness), FEELING ABNORMAL (Foggy feeling in brain), VACCINATION SITE ERYTHEMA (Vaccination site erythema), CONTUSION (Bruised) and VACCINATION SITE WARMTH (Hot to the touch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product information was not reported Treatment information was not provided

Other Meds:

Current Illness:

ID: 1550513
Sex: F
Age:
State: KY

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: feels sick all day; feels like she has a bug; cough; no strength; sore around injection site; headache; very tired; nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feels sick all day), MALAISE (feels like she has a bug), COUGH (cough), ASTHENIA (no strength) and VACCINATION SITE PAIN (sore around injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history reported. Concurrent medical conditions included Diabetes mellitus and Hypertension. Concomitant products included Insulin fast acting for Diabetes mellitus, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) for an unknown indication. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced MALAISE (feels sick all day), MALAISE (feels like she has a bug), COUGH (cough), ASTHENIA (no strength), VACCINATION SITE PAIN (sore around injection site), HEADACHE (headache), FATIGUE (very tired) and NAUSEA (nausea). At the time of the report, MALAISE (feels sick all day), MALAISE (feels like she has a bug), COUGH (cough), ASTHENIA (no strength), VACCINATION SITE PAIN (sore around injection site), HEADACHE (headache), FATIGUE (very tired) and NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. treatment include cough drops. Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: The follow-up was received on 26-APR-2021 and include NNI

Other Meds: Insulin fast acting; JANUVIA [SITAGLIPTIN PHOSPHATE]

Current Illness: Diabetes mellitus; Hypertension

ID: 1550514
Sex: F
Age: 55
State: TX

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: injection site swelling; injection site knot; injection site tenderness; injection site black; injection site has a scab; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (injection site swelling), INJECTION SITE INDURATION (injection site knot), INJECTION SITE PAIN (injection site tenderness), INJECTION SITE DISCOLOURATION (injection site black) and INJECTION SITE SCAB (injection site has a scab) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical information provided). On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (injection site swelling), INJECTION SITE INDURATION (injection site knot), INJECTION SITE PAIN (injection site tenderness), INJECTION SITE DISCOLOURATION (injection site black) and INJECTION SITE SCAB (injection site has a scab). At the time of the report, INJECTION SITE SWELLING (injection site swelling), INJECTION SITE INDURATION (injection site knot), INJECTION SITE PAIN (injection site tenderness), INJECTION SITE DISCOLOURATION (injection site black) and INJECTION SITE SCAB (injection site has a scab) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant medication nor treatment provided

Other Meds:

Current Illness:

ID: 1550515
Sex: F
Age: 71
State: CA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: pain in the nipple; breast pain was in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of NIPPLE PAIN (pain in the nipple) and BREAST PAIN (breast pain was in the left arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced NIPPLE PAIN (pain in the nipple) and BREAST PAIN (breast pain was in the left arm). At the time of the report, NIPPLE PAIN (pain in the nipple) and BREAST PAIN (breast pain was in the left arm) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: benign benign. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient was expected to receive second dose of vaccine on 04-Feb-2021 but she did not decide which arm to get second dose.

Other Meds:

Current Illness:

ID: 1550516
Sex: F
Age: 74
State: MI

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Pain; Sweat; Fever; Chills; Body aches; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), HYPERHIDROSIS (Sweat), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Pain), HYPERHIDROSIS (Sweat), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Myalgia, Chills, Fever, Pain, Sweaty and Tiredness, at an unspecified dose and frequency. At the time of the report, PAIN (Pain), HYPERHIDROSIS (Sweat), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Tiredness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided.

Other Meds:

Current Illness:

ID: 1550517
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: lazy; severe headache; feel tired; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1550518
Sex: F
Age: 75
State:

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: injection site is severely itchy; injection site is bright red; right arm was red; right arm was hard; right arm was itchy; right arm was painful; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (right arm was red), INDURATION (right arm was hard), PRURITUS (right arm was itchy), PAIN IN EXTREMITY (right arm was painful) and VACCINATION SITE PRURITUS (injection site is severely itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included APIXABAN (ELIQUIS) for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced ERYTHEMA (right arm was red), INDURATION (right arm was hard), PRURITUS (right arm was itchy) and PAIN IN EXTREMITY (right arm was painful). On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (injection site is severely itchy) and VACCINATION SITE ERYTHEMA (injection site is bright red). On 02-Feb-2021, ERYTHEMA (right arm was red), INDURATION (right arm was hard), PRURITUS (right arm was itchy) and PAIN IN EXTREMITY (right arm was painful) had resolved. At the time of the report, VACCINATION SITE PRURITUS (injection site is severely itchy) and VACCINATION SITE ERYTHEMA (injection site is bright red) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not reported. Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2021: No new information was reported

Other Meds: ELIQUIS

Current Illness:

ID: 1550519
Sex: F
Age: 78
State:

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Red; seems to grow; Tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Tender), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (seems to grow) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The patient's past medical history included Pneumonia. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (Tender). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (seems to grow). At the time of the report, VACCINATION SITE PAIN (Tender), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (seems to grow) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant information provided. No treatment information provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 26 October 2021 2:21am